Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2025-05-14 2025-05-14
Drug Identification Number 00795879 00795879
Brand name HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ) HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ)
Common or Proper name 30% insulin injection, 70% insulin isophane, human biosynthetic (rDNA origin) 30% insulin injection, 70% insulin isophane, human biosynthetic (rDNA origin)
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients INSULIN ISOPHANE INSULIN INSULIN ISOPHANE INSULIN
Strength(s) 70UNIT 30UNIT 70UNIT 30UNIT
Dosage form(s) SUSPENSION SUSPENSION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size Vial HI0710, 10 mL, 100 units/mL Vial HI0710, 10 mL, 100 units/mL
ATC code A10AD A10AD
ATC description INSULINS AND ANALOGUES INSULINS AND ANALOGUES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2026-04-30 2026-04-30
Actual discontinuation date
Remaining supply date 2026-04-30 2026-04-30
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments